Assignee
MTI BIOTECH INC
US·2 granted patents·4 pending applications·0 citations·filing 2020–2025
Top patents by PatentIndex Score
6 records- 0179US2026035337A1Triphenylphosphonium-tethered salicylamine derivativesMTI BIOTECH INC·Filed 2025·Application pending·0 cites
- 0274US12383515B2Compositions and methods of use of γ-ketoaldehyde scavengers for treating, preventing or improving nonalcoholic fatty liver disease (NAFLD), NASH, ALD or conditions related to the liverMTI BIOTECH INC·Filed 2022·Granted Aug 12, 2025·0 cites·6 claims
- 0374US2025360094A1Compositions and methods of use of gamma-ketoaldehyde scavengers for treating, preventing or improving nonalcoholic fatty liver disease (nafld), nash, ald or conditions related to the liverMTI BIOTECH INC·Filed 2025·Application pending·0 cites
- 0467US2023330049A1Compositions and methods of use of gamma-ketoaldheyde scavengers for treating, preventing or improving fibrosis of the liverMTI BIOTECH INC·Filed 2023·Application pending·0 cites
- 0563US12435025B2Triphenylphosphonium-tethered salicylamine derivativesMTI BIOTECH INC·Filed 2020·Granted Oct 7, 2025·0 cites·9 claims
- 0655US2021023032A1Compositions and methods of use of gamma-ketoaldheyde scavengers for treating, preventing or improving fibrosis of the liverMTI BIOTECH INC·Filed 2020·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →